Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor

doi:10.1111/1759-7714.14693

HFCAS OpenIR

	Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
	Wang, Wenxian 1; Wang, Qian 2; Xu, Chunwei 3,4; Li, Ziming 5; Song, Zhengbo 1; Zhang, Yongchang 6; Cai, Xiuyu 7; Zhang, Shirong 8; Lian, Bin 9; Li, Wen 10; Liu, Anwen 11; Zhan, Ping 4; Liu, Hongbing 4; Lv, Tangfeng 4; Miao, Liyun 12; Min, Lingfeng 13; Chen, Yu14,15 ; Yuan, Jingping 16; Wang, Feng17 ; Jiang, Zhansheng 18; Lin, Gen 14,15; Pu, Xingxiang 19,20; Rao, Chuangzhou 21; Lv, Dongqing 22; Yu, Zongyang 23; Li, Xiaoyan 24; Tang, Chuanhao 25; Zhou, Chengzhi 26; Xie, Congying 27; Zhang, Junping 28; Guo, Hui 29; Chu, Qian 30; Meng, Rui 31; Wu, Jingxun 32; Zhang, Rui33 ; Wang, Liping 34; Zhu, Youcai 35; Hu, Xiao 36; Xie, Yanru 37; Lin, Xinqing 26; Cai, Jing 11; Lan, Fen 10; Feng, Huijing 28; Wang, Lin 38; Yao, Wang 39; Shi, Xuefei 40; Huang, Jianhui 37; Chen, Huafei 35; Zhang, Yinbin 41; Sun, Pingli 42; Wan, Bing 43; Pang, Fei 44; Xu, Zanmei 44; Wang, Kai 44; Xia, Yuanli 45; Ye, Mingxiang 4; Wang, Dong 4; Wei, Qing 1; Feng, Shuitu 46; Zhou, Jianya 47; Zhang, Jiexia 26; Lv, Donglai 48; Gao, Wenbin 49; Kang, Jing 50; Yu, Genhua 51; Liang, Xianbin 52; Yu, Chengtao 53; Shi, Lin 54; Yang, Nong 6; Wu, Lin19,20 ; Hong, Zhuan 55; Hong, Wei 1; Fang, Meiyu 1; Zhang, Yiping 1; Lu, Yuanzhi 56; Wang, Guansong 57; Ma, Shenglin 58; Si, Lu 9; Fang, Wenfeng 59; Song, Yong 4
	2022-10-21
发表期刊	THORACIC CANCER
ISSN	1759-7706
通讯作者	Si, Lu(silu15_silu@126.com) ; Fang, Wenfeng(fangwf@sysucc.org.cn) ; Song, Yong(yong.song@nju.edu.cn)
摘要	Immune checkpoint inhibitors (ICIs) have successfully treated a number of different types of cancer, which is of great significance for cancer treatment. With the widespread use of ICIs in clinical practice, the increasing checkpoint inhibitor pneumonia (CIP) will be a challenge to clinicians. To guide the diagnosis and treatment of CIP, we conducted in-depth discussions based on the latest evidence, forming a consensus among Chinese experts on the multidisciplinary management of CIP.
关键词	checkpoint inhibitor pneumonitis Chinese experts consensus immune checkpoint inhibitor-related adverse effects
DOI	10.1111/1759-7714.14693
关键词[WOS]	CELL LUNG-CANCER ; ADVERSE EVENTS ; PD-1/PD-L1 INHIBITORS ; SAFETY ; EFFICACY ; IMMUNOTHERAPY ; ANTI-PD-1 ; MELANOMA ; NSCLC ; CHEMOTHERAPY
收录类别	SCI
语种	英语
WOS研究方向	Oncology ; Respiratory System
WOS类目	Oncology ; Respiratory System
WOS记录号	WOS:000877840500001
出版者	WILEY
引用统计	被引频次：3[WOS] [WOS记录] [WOS相关记录]
文献类型	期刊论文
条目标识符	http://ir.hfcas.ac.cn:8080/handle/334002/130207
专题	中国科学院合肥物质科学研究院
通讯作者	Si, Lu; Fang, Wenfeng; Song, Yong
作者单位	1.Chinese Acad Sci Univ Canc Hosp, Dept Chemotherapy, Zhejiang Canc Hosp, Hangzhou, Peoples R China 2.Nanjing Univ Chinese Med, Jiangsu Prov Hosp Chinese Med, Dept Resp Med, Affiliated Hosp, Nanjing, Peoples R China 3.Chinese Acad Sci, Inst Canc & Basic Med ICBM, Hangzhou, Peoples R China 4.Nanjing Univ, Affiliated Jinling Hosp, Dept Resp Med, Med Sch, Nanjing 210002, Jiangsu, Peoples R China 5.Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Shanghai Lung Canc Ctr, Shanghai, Peoples R China 6.Cent South Univ, Dept Med Oncol,Xiangya Sch Med, Lung Canc & Gastrointestinal Unit, Hunan Canc Hosp,Affiliated Canc Hosp, Changsha, Peoples R China 7.Sun Yet Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept VIP Inpatient, State Key Lab Oncol South China, Guangzhou, Peoples R China 8.Zhejiang Univ, Translat Med Res Ctr, Key Lab Clin Canc Pharmacol & Toxicol Res Zhejian, Affiliated Hangzhou Peoples Hosp 1,Canc Ctr, Hangzhou, Peoples R China 9.Peking Univ Canc Hosp & Inst, Dept Melanoma & Sarcoma, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, Beijing, Peoples R China 10.Zhejiang Univ, Key Lab Resp Dis Zhejiang Prov, Dept Resp & Crit Care Med, Affiliated Hosp 2,Sch Med,Canc Ctr, Hangzhou, Peoples R China 11.Nanchang Univ, Dept Oncol, Affiliated Hosp 2, Nanchang, Peoples R China 12.Nanjing Univ, Dept Resp Med, Affiliated Drum Tower Hosp, Med Sch, Nanjing, Peoples R China 13.Yangzhou Univ, Subei Peoples Hosp Jiangsu Prov, Dept Resp Med, Clin Med Sch, Yangzhou, Jiangsu, Peoples R China 14.Fujian Med Univ Canc Hosp, Dept Med Oncol, Fuzhou, Peoples R China 15.Fujian Canc Hosp, Fuzhou, Peoples R China 16.Wuhan Univ, Dept Pathol, Renmin Hosp, Wuhan, Peoples R China 17.Nanjing Univ, Affiliated Jinling Hosp, Canc Ctr PLA, Dept Internal Med,Med Sch,Qinhuai Med Area, Nanjing, Peoples R China 18.Tianjin Med Univ Canc Inst & Hosp, Dept Integrat Oncol, Tianjin, Peoples R China 19.Cent South Univ, Dept Med Oncol, Lung Canc, Xiangya Sch Med, Changsha, Peoples R China 20.Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, Hunan Canc Hosp, Changsha, Peoples R China 21.Univ Chinese Acad Sci, Hwamei Hosp, Dept Radiotherapy & Chemotherapy, Ningbo, Peoples R China 22.Wenzhou Med Univ, Dept Pulm Med, Taizhou Hosp, Taizhou, Peoples R China 23.Fujian Med Univ, Hosp 900, Dept Resp Med, Joint Logist Team,Fuzhou Gen Hosp, Fuzhou, Peoples R China 24.Capital Med Univ, Beijing Tiantan Hosp, Dept Oncol, Beijing, Peoples R China 25.Peking Univ Int Hosp, Dept Med Oncol, Beijing, Peoples R China 26.Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,Affiliated Hosp 1, Guangzhou, Peoples R China 27.Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, Wenzhou, Peoples R China 28.Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Thorac Oncol, Taiyuan, Peoples R China 29.Xi An Jiao Tong Univ, Dept Med Oncol, Affiliated Hosp 1, Xian, Peoples R China 30.Huazhong Univ Sci & Technol, Tongji Hosp, Dept Oncol, Tongji Med Coll, Wuhan, Peoples R China 31.Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Canc Ctr, Wuhan, Peoples R China 32.Xiamen Univ, Affiliated Hosp Med 1, Dept Med Oncol, Xiamen, Peoples R China 33.China Med Univ, Dept Med Oncol, Canc Hosp, Shenyang, Peoples R China 34.Baotou Canc Hosp, Dept Oncol, Baotou, Peoples R China 35.Jiaxing Univ, Affiliated Hosp 3, Zhejiang Rongjun Hosp, Dept Thorac Dis,Diag & Treatment Ctr, Jiaxing, Peoples R China 36.Univ Chinese Acad Sci, Zhejiang Key Lab Radiat Oncol, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China 37.Lishui Municipal Cent Hosp, Dept Oncol, Lishui, Peoples R China 38.Shanxi Acad Med Sci, Shanxi Bethune Hosp, Dept Pathol, Taiyuan, Peoples R China 39.Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Peoples R China 40.Zhejiang Univ, Huzhou Hosp, Dept Resp Med, Sch Med, Huzhou, Peoples R China 41.Xi An Jiao Tong Univ, Med Coll, Dept Oncol, Affiliated Hosp 2, Xian, Peoples R China 42.Second Hosp Jilin Univ, Dept Pathol, Changchun, Peoples R China 43.Nanjing Med Univ, Dept Resp Med, Affiliated Jiangning Hosp, Nanjing, Peoples R China 44.Shanghai OrigiMed Co Ltd, Dept Med, Shanghai, Peoples R China 45.AstraZeneca China, Dept Med Affairs, Shanghai, Peoples R China 46.Xiamen Haicang Hosp, Dept Oncol, Xiamen, Peoples R China 47.Zhejiang Univ, Affiliated Hosp 1, Thorac Dis Ctr, Sch Med, Hangzhou, Peoples R China 48.Joint Logist Support Force People Liberat Army, Dept Clin Oncol, Hosp 901, Hefei, Peoples R China 49.Shenzhen Univ, Dept Oncol, Affiliated Hosp 3, Shenzhen, Peoples R China 50.Guangdong Acad Med Sci, Guangdong Lung Canc Inst, Guangdong Prov Lab Translat Med Lung Canc, Guangdong Prov Peoples Hosp,Sch Med, Guangzhou, Peoples R China 51.Zhebei Mingzhou Hosp, Dept Radiat Oncol, Huzhou, Peoples R China 52.Third Peoples Hosp Zhengzhou, Dept Oncol, Zhengzhou, Peoples R China 53.Collaborat Innovat Ctr Jiangsu Prov Canc Prevent, Nanjing, Peoples R China 54.Fudan Univ, Zhongshan Hosp, Dept Resp Med, Shanghai, Peoples R China 55.Nanjing Med Univ, Jiangsu Canc Hosp, Dept Med Oncol, Affiliated Canc Hosp, Nanjing, Peoples R China 56.Jinan Univ, Dept Clin Pathol, Affiliated Hosp 1, Guangzhou, Peoples R China 57.Third Mil Med Univ, Xinqiao Hosp, Inst Resp Dis, Chongqing, Peoples R China 58.Zhejiang Univ, Sch Med, Canc Ctr,Key Lab Clin Canc Pharmacol & Toxicol Re, Affiliated Hangzhou Canc Hosp,Dept Oncol, Hangzhou, Peoples R China 59.Sun Yat Sen Univ Canc Ctr, Dept Med Oncol, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Wang, Wenxian,Wang, Qian,Xu, Chunwei,et al. Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor[J]. THORACIC CANCER,2022.
APA	Wang, Wenxian.,Wang, Qian.,Xu, Chunwei.,Li, Ziming.,Song, Zhengbo.,...&Song, Yong.(2022).Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor.THORACIC CANCER.
MLA	Wang, Wenxian,et al."Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor".THORACIC CANCER (2022).